GFAP and neurodegenerative disease: Suppressing the hyperactivation of microglia and astrocytes is an essential factor for slowing the progression of neurodegenerative diseases (Nishimura et al. 2018); thus, lower brain GFAP and CD36 concentrations may indicate suppressed neuroinflammation.